WINCHESTER, ON, May 27, 2011 /CNW/ - Natunola Health Biosciences Inc.
(TSX-V:NHI) ("Natunola") is pleased to announce that its wholly owned subsidiary Natunola Health
Inc. received a new grant from the Ontario Ministry of Agriculture,
Food and Rural Affair ("OMAFRA") under the Rural Economic Development
program for a maximum of $312,250 for its low glycemic index maple
project. The project will implement the commercialization process of
new low glycemic index maple product. The product will be a first of
its kind offering in maple syrup products for consumers.
The product is aimed at diabetic and health conscious consumers and
seeks to build demand and new markets for Ontario produced maple syrup.
The new low glycemic maple product will be targeted for domestic and
export market such as US, Japan and Europe.
Natunola is collaborating with the National Research Council of Canada
("NRC") and the University of Guelph Kemptville Campus Agroforestry
Education and Research Center ("Kemptville Center") and Maple Ridge
Farm on this project. NRC scientists and Natunola scientists have
developed a patent pending process to convert sucrose within maple
syrup to isomaltulose, a low glycemic index sweetener currently being
utilized in low calorie beverages and food.
"The current trends in obesity will certainly increase the number of the
diabetic population worldwide. Thus, a new source of natural sweetener
such as isomaltulose will let the diabetic consumers and consumers in
general that require control of their sugar intake enjoy their daily
meal and life", said Dr. Nam Fong Han, President & CEO of Natunola.
Adding, "Ultimately, Canadians will benefit by having low glycemic
index maple products that are healthy and taste good".
There are approximately 30 million people in US and about 2.2 million
Canadians with diabetes who have to avoid foods with a high glycemic
index, including maple syrup. Thus, maple products with a low glycemic
index (GI < 56) which contain isomaltulose and that can be produced
directly or indirectly from the existing maple sap or maple syrup have
great market potential.
"We are confident that with the grant from OMAFRA and with the
successful launch of the new low glycemic index maple product in near
future, it will bring a positive impact to the Ontario economic and
will also bring great return to Natunola's shareholders", said Dr. Nam
Fong Han, President & CEO of Natunola.
About the Company:
Natunola and its manufacturing plant are located in Winchester, Ontario. Natunola is a manufacturer and researcher in the field of flax seed derived omega
-3 fatty acids, flax protein, flax lignans, specialty natural products,
bio-nutrients and functional supplements for human and animal care
markets. Natunola also produces canola oil gels and other natural
ingredients for the cosmetic and personal care industry. Natunola has a
retail health product line under the brand name of Natunola® health's
delight. Natunola was the winner for the National Canadian Agri-Food
Award of Excellence for Innovation for the year 2008.
Some of the statements contained in the release are forward-looking
statements, such as estimates and statements that describe the
Company's future plans, objectives or goals, including words to the
effect that the Company or management expects a stated condition or
result to occur. Since forward-looking statements address future events
and conditions, by their very nature, they involve inherent risks and
uncertainties. Actual results in each case could differ materially from
those currently anticipated in such statements.
The views expressed in this press release are the views of the Company
and do not necessary reflect those of OMAFRA.
The TSX Venture Exchange has not reviewed and does not accept
responsibility for the adequacy or accuracy of this press release.
SOURCE Natunola Health Biosciences Inc.
For further information:
Dr. Nam Fong Han
President & CEO
Natunola Health Biosciences Inc.
661, St Lawrence Street,
Tel (613) 774-9998